Logo image
Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat
Journal article   Peer reviewed

Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat

Berat Z. Haznedaroglu, Yavuz Beyazit, Sharon L. Walker and Ibrahim C. Haznedaroglu
Critical reviews in oncology/hematology, v 83(1)
01 Jul 2012
PMID: 22079213

Abstract

Hematology Life Sciences & Biomedicine Oncology Science & Technology
Sustaining hemostasis in clinical hemorrhages is a challenging task and requires extensive effort to stabilize medically hard-to-treat traumatic injuries. Several hemostatic agents are preferred to control external and internal bleedings, yet commercially available products are not sufficiently effective or fast-acting to achieve hemostasis in extreme cases. Anlcaferd Blood Stopper (ABS) is a herbal extract traditionally used as a hemostatic agent. Recent studies have shown that ABS could be utilized successfully as a hemostatic agent for the management of clinical hemorrhages when conventional methods were ineffective. This review serves as a basis to provide recent findings on several applications of ABS, specifically preclinical, biological, and clinical studies both in vitro and in vivo. Another section focuses on the ultrastructural morphology and protein network formation of ABS in an effort to understand the hemostatic mechanisms of this unique agent at tissue level. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

Metrics

9 Record Views
58 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Hematology
Oncology
Logo image